Alto Neuroscience has received FDA Fast Track designation for its [...]
Morphic Medical’s non-invasive weight loss device RESET is expected to [...]
FDA recognition accelerates development of first-in-class mitochondrial cell therapy for [...]
Alto Neuroscience has received FDA Fast Track designation for its [...]
Morphic Medical’s non-invasive weight loss device RESET is expected to [...]
FDA recognition accelerates development of first-in-class mitochondrial cell therapy for [...]